The TB Enigma:cracking the Code with a multifaceted Approach

Tuberculosis (TB) continues to be a significant global health challenge, intensified by drug-resistant forms such as multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB. Despite available treatments, challenges like prolonged therapy, side effects, and delayed diagnosis hinder effective control. Globally, TB remains one of the leading causes of death from a single infectious agent, with an estimated 10.8 million new cases and 1.25 million deaths reported in 2023. Key Developing Countries, notably India, China, and Indonesia, account for a disproportionate share of cases, showcasing the acute necessities in these regions. This review highlights the complex nature of TB infection and the limitations of traditional first- and second-line drugs, emphasizing issues like toxicity and drug interactions. Recent pharmaceutical progress, particularly the approval of novel agents such as Bedaquiline and Delamanid, marks an important step forward in treating resistant TB strains. Cutting-edge drug delivery technologies using nanotechnology and macrophage targeting improve drug stability, bioavailability, and reduce systemic toxicity. Furthermore, plant-based phytochemicals and immunomodulators offer promising adjunctive therapies to enhance immune responses and mitigate treatment side effects. This integrative approach holds the potential to transform TB management and accelerate progress toward the ultimate eradication of this ancient but preventable disease.

Authors

Institutions

Publication Details

Journal
International Journal of Innovation and Multidisciplinary Research
Published
2026-11-15
DOI
https://doi.org/10.67505/ijiamr.v6.i2.62008
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The TB Enigma:cracking the Code with a multifaceted Approach

Varsha Mehra, Gunjan Chalukya, Nisha Prakash
International Journal of Innovation and Multidisciplinary Research
Tuberculosis Research and Epidemiology
article

The TB Enigma:cracking the Code with a multifaceted Approach

Varsha Mehra, Gunjan Chalukya, Nisha Prakash
article en

Abstract

Tuberculosis (TB) continues to be a significant global health challenge, intensified by drug-resistant forms such as multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB. Despite available treatments, challenges like prolonged therapy, side effects, and delayed diagnosis hinder effective control. Globally, TB remains one of the leading causes of death from a single infectious agent, with an estimated 10.8 million new cases and 1.25 million deaths reported in 2023. Key Developing Countries, notably India, China, and Indonesia, account for a disproportionate share of cases, showcasing the acute necessities in these regions. This review highlights the complex nature of TB infection and the limitations of traditional first- and second-line drugs, emphasizing issues like toxicity and drug interactions. Recent pharmaceutical progress, particularly the approval of novel agents such as Bedaquiline and Delamanid, marks an important step forward in treating resistant TB strains. Cutting-edge drug delivery technologies using nanotechnology and macrophage targeting improve drug stability, bioavailability, and reduce systemic toxicity. Furthermore, plant-based phytochemicals and immunomodulators offer promising adjunctive therapies to enhance immune responses and mitigate treatment side effects. This integrative approach holds the potential to transform TB management and accelerate progress toward the ultimate eradication of this ancient but preventable disease.

International Journal of Innovation and Multidisciplinary ResearchVol. V6(I2)
University of Delhi (IN)
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
The TB Enigma:cracking the Code with a multifaceted Approach — Varsha Mehra, Gunjan Chalukya, et al. · International Journal of Innovation and Multidisciplinary Research (2026) | TGRS Research Map | TGRS